Featured Post
Why Automation Is Growing in Non-Sterile Compounding in the USA
Non-sterile compounding automation is reshaping how independent pharmacies in the United States operate. Driven by a convergence of regulatory demands, workforce constraints, and rising patient demand for personalized dosing, compounding pharmacy automation has moved from a niche consideration to a strategic priority for private pharmacies looking to remain competitive and compliant in 2026 and beyond.
PRESS RELEASE: Pharmacies' medicine compounding capability is part of security of supply — in Finland, it is thinning out
The decline of pharmacies' medication production capacity in Finland threatens healthcare resilience, prompting calls for a decentralized network of capable pharmacies.
LEHDISTÖTIEDOTE: Apteekkien lääkkeiden valmistuskyky on osa huoltovarmuutta — Suomessa se on ohentumassa
The decline of pharmacies' medication production capacity in Finland threatens healthcare resilience, prompting calls for a decentralized network of capable pharmacies.
CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine
CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine
NEWS FROM SWEDEN: First delivery of extemporaneous medicinal products manufactured using 3D technology
https://press.apl.se/posts/pressreleases/forsta-leveransen-av-extemporelakemedel-tillv
CurifyLabs Unveils Next Gen 3D Printer for Scalable Plug-and-Play Pharmaceutical Compounding
CurifyLabs PharmaPrinter Aurum
Press Release: CurifyLabs Launches CuraBlend®Vet, Bringing Breakthrough 3D-Printed, Personalized Medicines to Pets
CurifyLabs introduces CuraBlend®Vet, a 3D-printed, flavored gel tablet for pets, improving adherence and simplifying medication administration with personalized dosages.
Press Release: New data shows compounded medicines tackle the unmet needs and improve adherence to treatment for pediatric cancers
Press release CurifyLabs New data shows compounded medicines tackle the unmet needs and improve adherence to treatment for pediatric cancers.
CurifyLabs Leads €5.6M EU-Funded RoboPharma Project and raised €6.7M to Modernise Personalised Medicine!
CurifyLabs raises €6.7M and leads a €5.6M EU-funded RoboPharma project to revolutionize the manufacturing of personalized medicine with automation and AI.
APL and CurifyLabs partnership to support critically ill patients with 3D printing medicine technology
CurifyLabs to partner with APL
CurifyLabs’ Technology Validated in European-Wide Study
CurifyLabs peer reviewed article, Delpech Paris, Charite, Helios, Lausanne University Hospital, Mainz University Hospital